Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NHE inhibitor BIIB-513 protects against ischemia/reperfusion injury in dogs

Oct. 22, 1998

Knoll terminates verapamil collaboration with Chiroscience; company seeks new partners

Oct. 21, 1998

U.S. launch announced for Atacand

Oct. 21, 1998

Dronedarone preclinical data: electrophysiological, hemodynamic and antiarrhythmic effects in dogs

Oct. 21, 1998

Taisho describes antiischemic 2-phenoxyaniline derivatives

Oct. 20, 1998

United Therapeutics reports successful completion of pilot study in PVD

Oct. 15, 1998

Novel Lp(a)-lowering agents prepared by SKB-Symphar team

Oct. 15, 1998

Nobel award brings nitric oxide into the limelight

Oct. 14, 1998

COHERE will track long-term effects of beta-blockade in heart failure

Oct. 14, 1998

Antiatherogenic activity of antioxidant BO-653 explored in animal models

Oct. 13, 1998

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...